60 Degrees Pharmaceutical... (SXTP)
NASDAQ: SXTP
· Real-Time Price · USD
2.44
-0.24 (-8.96%)
At close: May 01, 2025, 3:59 PM
2.30
-5.74%
Pre-market: May 02, 2025, 05:27 AM EDT
-8.96% (1D)
| Bid | 2.23 |
| Market Cap | 3.59M |
| Revenue (ttm) | 637.93K |
| Net Income (ttm) | -7.95M |
| EPS (ttm) | -18.55 |
| PE Ratio (ttm) | -0.13 |
| Forward PE | -3.66 |
| Analyst | n/a |
| Ask | 2.56 |
| Volume | 65,760 |
| Avg. Volume (20D) | 1,744,243 |
| Open | 2.63 |
| Previous Close | 2.68 |
| Day's Range | 2.42 - 2.70 |
| 52-Week Range | 1.41 - 36.00 |
| Beta | 3.42 |
About SXTP
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, cand...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 12, 2023
Employees 3
Stock Exchange NASDAQ
Ticker Symbol SXTP
Website https://60degreespharma.com
Next Earnings Release
60 Degrees Pharmaceuticals Inc. is scheduled to release its earnings on May 14, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+59.44%
60 Degrees Pharmaceuticals shares are trading high...
Unlock content with
Pro Subscription
2 months ago
-14.09%
60 Degrees Pharmaceuticals shares are trading lower after the company announced a $1.075 million registered direct offering.
